HCV Treatment Initiation in Patients with Chronic Kidney Disease: Results from ERCHIVES

BACKGROUND: Newer directing antiviral agents against HCV (DAAs) are safe and efficacious in persons with chronic kidney disease (CKD). Whether availability of these newer DAAs has resulted in more persons with CKD initiating HCV treatment remains unknown. METHODS: We identified HCV+ persons in ERCHI...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Butt, Adeel, Ren, Yanjie, Puenpatom, Amy, Arduino, Jean Marie, Kumar, Ritesh, Abou-Samra, Abdul-Badi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632023/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.384
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars